Tyler Greenlee, DO
Ophthalmology · Columbus, OHNPI 1447887450
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $795 and has fallen 66.3% since, to $268 in 2025.
Across 39 payments — averaging $57.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$449
- Alcon$442
- Bausch & Lomb Americas Inc.$392
- AbbVie$258
- Sight Sciences, Inc.$155
- Apellis Pharmaceuticals, Inc.$123
- plus $418 from 10 others
What the payments were for
- Food & beverage$2,238100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 4 | $449 |
| Alcon | 9 | $442 |
| Bausch & Lomb Americas Inc. | 4 | $392 |
| AbbVie | 4 | $258 |
| Sight Sciences, Inc. | 2 | $155 |
| Apellis Pharmaceuticals, Inc. | 1 | $123 |
| Rxsight Inc | 1 | $112 |
| Glaukos Corporation | 4 | $86 |
| Harrow Eye, LLC | 2 | $47 |
| Tarsus Pharmaceuticals, Inc. | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
| Carl Zeiss Meditec USA, Inc. | 1 | $28 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| NEW World Medical,inc. | 1 | $18 |
| Oyster Point Pharma, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$352
- enVista MX60 IOL$277
- STELLARIS$176
- AMVISC PLUS$176
- OMNI(R) SURGICAL SYSTEM (US)$140
- Clareon$136
- DURYSTA$125
- Syfovre$123
- RXSIGHT CONTACT LENS$112
- RXSIGHT INJECTOR CARTRIDGE$112
- RXSIGHT INJECTOR HANDPIECE$112
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$112
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$112
- Centurion$111
How this compares
$2,238 in reported general payments places this provider in the 65th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 24 | $1,080 |
| MoxifloxacinMoxifloxacin Hcl | 22 | $558 |
| Ketorolac Tromethamine | 22 | $371 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Columbus
- Alice EpitropoulosColumbus$531K
- Steven KatzColumbus$256K
- David LehmannColumbus$58K
- Lisa BorkowskiColumbus$25K
- Thomas MendelColumbus$15K
- Norman BakerColumbus$11K
- Carrie LembachColumbus$11K
- John ChristoforidisColumbus$10K
- Peter KaiserCleveland$1.5M
- Gregory EippertMentor$813K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.